查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1877611

2025年全球异位性皮肤炎数位疗法市场报告

Digital Therapeutics For Atopic Dermatitis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，异位性皮肤炎的数位疗法市场发展迅速，预计将从2024年的4.7亿美元成长到2025年的5.7亿美元，复合年增长率达21.6%。过去几年的成长可归因于医疗保健领域数位化进程的不断推进、製药公司与科技公司之间合作的日益密切、监管部门对数位疗法的支持力度加大、保险覆盖范围和报销计划的扩大，以及居家照护解决方案的日益普及。

预计未来几年，异位性皮肤炎数位疗法市场将快速成长，到2029年市场规模将达到12.4亿美元，复合年增长率（CAGR）为21.3%。预测期内的成长要素包括：行动医疗应用的日益普及、对提高患者依从性和治疗效果的日益重视、远端医疗和远端患者监护的广泛应用、政府对数位医疗的支持力度加大以及相关法规的优化，以及新兴经济体市场渗透率的不断提高。预测期内的主要趋势包括：软体和设备的技术进步、基于人工智慧的患者管理创新、行动医疗应用开发的快速发展、生物製药整合方面的研发以及数位疗法平台的持续改进。

预计未来几年，智慧型手机普及率的不断提高将推动特应性皮肤炎数位疗法市场的成长。智慧型手机是一种便携式设备，集通讯、网路连接和运算功能于一体。其普及主要得益于网路普及率的不断提高，使更多人能够方便地存取线上服务、社群媒体和数位内容。智慧型手机的高普及率将促进异位性皮肤炎数位疗法的发展。患者可以无缝存取行动应用程式和数位平台，从而实现即时症状追踪、治疗提醒和个人化指导，最终提高治疗依从性和疾病管理水平。例如，英国比价和切换服务供应商Uswitch Limited在2023年2月发布的报告预测，2022年英国的活跃行动连线将达到7,180万，到2025年，英国6,830万人口中将有95%的人拥有智慧型手机。因此，智慧型手机使用量的成长预计将推动异位性皮肤炎数位疗法市场的成长。

异位性皮肤炎数位疗法市场的主要企业正专注于早期投资，以促进创新和成长。这些种子轮融资不仅为Start-Ups创业公司提供资金支持，还提供导师指导、产业网络和策略支援。例如，总部位于德国的AI驱动型皮肤病成像解决方案供应商Nia Health于2023年5月宣布成功完成410万美元（350万欧元）的种子轮资金筹措。这项投资将使该公司能够进一步开发其在柏林夏里特大学医院开发的异位性皮肤炎数位疗法应用程式。该资金将有助于该公司巩固其在德语市场的地位，并在未来两年内加速拓展至其他欧盟国家，同时为进军美国市场做好准备。该公司还计划加速开发其应用程式的AI驱动功能，包括机器视觉、自然语言处理和远端皮肤科会诊功能。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球异位性皮肤炎数位疗法市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球异位性皮肤炎数位疗法市场：成长率分析
  • 全球异位性皮肤炎数位疗法市场：规模与成长，2019-2024年
  • 全球异位性皮肤炎数位疗法市场预测：规模与成长，2024-2029年，2034年预测
  • 全球异位性皮肤炎数位疗法市场：潜在市场规模 (TAM)

第六章 市场细分

  • 全球异位性皮肤炎数位疗法市场：依产品类型、表现和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 软体应用
  • 装置
  • 平台
  • 全球异位性皮肤炎数位治疗药物市场：按应用、性能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 疾病管理
  • 预防医学
  • 治疗支持
  • 全球异位性皮肤炎数位疗法市场：依最终用户划分，结果及预测，2019-2024年、2024-2029年预测、2034年预测
  • 患者
  • 医疗保健提供者
  • 付款人
  • 其他最终用户
  • 全球异位性皮肤炎数位治疗药物市场：依通路划分，结果及预测，2019-2024年、2024-2029年预测、2034年预测
  • 在线的
  • 离线
  • 全球异位性皮肤炎数位疗法市场：按软体应用、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 行动应用
  • Web应用程式
  • 桌面应用程式
  • 云端基础的应用
  • 全球异位性皮肤炎数位疗法市场：按设备、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 穿戴式装置
  • 监控设备
  • 诊断设备
  • 治疗设备
  • 全球异位性皮肤炎数位疗法市场：按平台、类型、表现和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 病患管理平台
  • 临床医生支援平台
  • 数据分析平台
  • 远端医疗平台

第七章 区域和国家分析

  • 全球异位性皮肤炎数位疗法市场：依地区划分，结果及预测，2019-2024年、2024-2029年预测、2034年预测
  • 全球异位性皮肤炎数位疗法市场：依国家划分，结果及预测，2019-2024 年、2024-2029 年预测、2034 年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 异位性皮肤炎数位疗法市场：竞争格局
  • 异位性皮肤炎数位疗法市场：公司概况
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Sanofi Overview, Products and Services, Strategy and Financial Analysis
    • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
    • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Otsuka Pharmaceutical Co. Ltd.
  • OMRON Corporation
  • Galderma SA
  • Incyte Corporation
  • Chugai Pharmaceutical Co. Ltd.
  • Teladoc Health Inc.
  • LEO Pharma A/S
  • Almirall SA
  • Biofourmis Inc.
  • Click Therapeutics Inc.
  • DarioHealth Corp.
  • Sidekick Health GmbH
  • Digital Diagnostics Inc.
  • Liva Healthcare A/S
  • 3Derm Systems

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年异位性皮肤炎数位疗法市场：提供新机会的国家
  • 2029年异位性皮肤炎数位疗法市场：蕴藏新机会的细分领域
  • 2029年异位性皮肤炎数位疗法市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r39196

Digital therapeutics for atopic dermatitis are technology-based interventions that utilize clinically validated software to assist in managing the condition. These therapeutics aim to influence patient behavior and offer research-based guidance to enhance treatment adherence, symptom management, and overall skin health.

The main product types of digital therapeutics for atopic dermatitis include software applications, devices, and platforms. Software applications are digital programs developed to perform specific functions and deliver therapeutic interventions through computers or mobile devices. They are used for disease management, preventive care, and treatment support and are utilized by various end users, including patients, healthcare providers, payers, and others. The distribution channels include both online and offline modes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The digital therapeutics for atopic dermatitis market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics for atopic dermatitis market statistics, including digital therapeutics for atopic dermatitis industry global market size, regional shares, competitors with a digital therapeutics for atopic dermatitis market share, detailed digital therapeutics for atopic dermatitis market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics for atopic dermatitis industry. This digital therapeutics for atopic dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics for the atopic dermatitis market size has grown exponentially in recent years. It will grow from $0.47 billion in 2024 to $0.57 billion in 2025 at a compound annual growth rate (CAGR) of 21.6%. The growth during the historic period can be attributed to increasing healthcare digitalization initiatives, expanding collaborations between pharmaceutical and technology companies, growing regulatory support for digital therapeutics, rising insurance coverage and reimbursement programs, and the increasing adoption of home-based care solutions.

The digital therapeutics for the atopic dermatitis market size is expected to see exponential growth in the next few years. It will grow to $1.24 billion in 2029 at a compound annual growth rate (CAGR) of 21.3%. The growth in the forecast period can be attributed to the rising adoption of mobile health applications, increasing focus on improving patient adherence and outcomes, growing use of telehealth and remote patient monitoring, expanding government support and favorable regulations for digital health, and increasing market penetration in emerging economies. Key trends during the forecast period include technological advancements in software and devices, innovations in AI-based patient management, progress in mobile health application development, research and development in biologics integration, and continuous improvements in digital therapeutic platforms.

The rising adoption of smartphones is expected to drive the growth of the digital therapeutics for atopic dermatitis market in the coming years. Smartphones are portable devices that combine communication, internet connectivity, and computing capabilities in one unit. Their growing adoption is primarily driven by increasing internet penetration, which enables more people to conveniently access online services, social media, and digital content. High smartphone usage supports digital therapeutics for atopic dermatitis by providing patients with seamless access to mobile applications and digital platforms that allow real-time symptom tracking, treatment reminders, and personalized guidance, ultimately improving adherence and disease management. For example, in February 2023, according to a report by Uswitch Limited, a UK-based comparison and switching service provider, there were 71.8 million active mobile connections in 2022, and by 2025, 95 percent of the 68.3 million people in the UK are expected to own smartphones. Therefore, the growing use of smartphones is anticipated to fuel the expansion of the digital therapeutics for atopic dermatitis market.

Major companies in the digital therapeutics for atopic dermatitis market are focusing on early-stage investments to foster innovation and growth. These seed funds not only provide financial backing but also mentorship, industry connections, and strategic support to emerging startups. For instance, in May 2023, Nia Health, a Germany-based provider of AI-powered dermatological imaging solutions, announced the successful completion of a $4.1 million (€3.5 million) seed funding round. This investment will help the company further develop its digital therapeutics application for atopic dermatitis, originally developed at Charite Universitatsmedizin Berlin. The funding will strengthen the company's presence in German-speaking markets, facilitate expansion into other European Union countries over the next two years, and prepare for entry into the US market. It will also accelerate advancements in the app's AI-driven features, including machine vision, natural language processing, and teledermatology functionalities.

In December 2023, Aptar Digital Health, a US-based digital health solutions provider, partnered with Legit.Health to advance immuno-dermatology care. Through this collaboration, Aptar's Digital Health platform integrates Legit.Health's advanced technology, capable of assisting in the diagnosis of nearly 300 conditions, including atopic dermatitis, psoriasis, and skin cancer. This integration aims to enhance patient care and engagement by enabling healthcare professionals to identify skin conditions earlier, allowing patients to begin treatment sooner and improve their overall quality of life. Legit.Health is a Spain-based medical software company specializing in AI-driven dermatological tools.

Major players in the digital therapeutics for atopic dermatitis market are Pfizer Inc., AbbVie Inc., Sanofi, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd., OMRON Corporation, Galderma S.A., Incyte Corporation, Chugai Pharmaceutical Co. Ltd., Teladoc Health Inc., LEO Pharma A/S, Almirall S.A., Biofourmis Inc., Click Therapeutics Inc., DarioHealth Corp., Sidekick Health GmbH, Digital Diagnostics Inc., Liva Healthcare A/S, and 3Derm Systems.

North America was the largest region in the digital therapeutics for atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital therapeutics for atopic dermatitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the digital therapeutics for atopic dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics for atopic dermatitis market consists of revenues earned by entities by providing services such as personalized treatment plans, symptom tracking, and teleconsultation support. The market value includes the value of related goods sold by the service provider or included within the service offering. the digital therapeutics for atopic dermatitis market also includes sales of smart patches, wearable sensors, skin imaging devices, and portable dermatoscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics For Atopic Dermatitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics for atopic dermatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics for atopic dermatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics for atopic dermatitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Software Applications; Devices; Platforms
  • 2) By Application: Disease Management; Preventive Care; Treatment Support
  • 3) By End-User: Patients; Healthcare Providers; Payers; Other End-Users
  • 4) By Distribution Channel: Online; Offline
  • Subsegments:
  • 1) By Software Applications: Mobile Applications; Web Applications; Desktop Applications; Cloud-Based Applications
  • 2) By Devices: Wearable Devices; Monitoring Devices; Diagnostic Devices; Therapeutic Devices
  • 3) By Platforms: Patient Management Platforms; Clinician Support Platforms; Data Analytics Platforms; Telehealth Platforms
  • Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Sanofi; Eli Lilly and Company; Boehringer Ingelheim International GmbH; Otsuka Pharmaceutical Co. Ltd.; OMRON Corporation; Galderma S.A.; Incyte Corporation; Chugai Pharmaceutical Co. Ltd.; Teladoc Health Inc.; LEO Pharma A/S; Almirall S.A.; Biofourmis Inc.; Click Therapeutics Inc.; DarioHealth Corp.; Sidekick Health GmbH; Digital Diagnostics Inc.; Liva Healthcare A/S; 3Derm Systems.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Therapeutics For Atopic Dermatitis Market Characteristics

3. Digital Therapeutics For Atopic Dermatitis Market Trends And Strategies

4. Digital Therapeutics For Atopic Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics For Atopic Dermatitis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Digital Therapeutics For Atopic Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Digital Therapeutics For Atopic Dermatitis Market Growth Rate Analysis
  • 5.4. Global Digital Therapeutics For Atopic Dermatitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Digital Therapeutics For Atopic Dermatitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Digital Therapeutics For Atopic Dermatitis Total Addressable Market (TAM)

6. Digital Therapeutics For Atopic Dermatitis Market Segmentation

  • 6.1. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software Applications
  • Devices
  • Platforms
  • 6.2. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disease Management
  • Preventive Care
  • Treatment Support
  • 6.3. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patients
  • Healthcare Providers
  • Payers
  • Other End-Users
  • 6.4. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Online
  • Offline
  • 6.5. Global Digital Therapeutics For Atopic Dermatitis Market, Sub-Segmentation Of Software Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mobile Applications
  • Web Applications
  • Desktop Applications
  • Cloud-Based Applications
  • 6.6. Global Digital Therapeutics For Atopic Dermatitis Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable Devices
  • Monitoring Devices
  • Diagnostic Devices
  • Therapeutic Devices
  • 6.7. Global Digital Therapeutics For Atopic Dermatitis Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Patient Management Platforms
  • Clinician Support Platforms
  • Data Analytics Platforms
  • Telehealth Platforms

7. Digital Therapeutics For Atopic Dermatitis Market Regional And Country Analysis

  • 7.1. Global Digital Therapeutics For Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Digital Therapeutics For Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market

  • 8.1. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics For Atopic Dermatitis Market

  • 9.1. China Digital Therapeutics For Atopic Dermatitis Market Overview
  • 9.2. China Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics For Atopic Dermatitis Market

  • 10.1. India Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics For Atopic Dermatitis Market

  • 11.1. Japan Digital Therapeutics For Atopic Dermatitis Market Overview
  • 11.2. Japan Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics For Atopic Dermatitis Market

  • 12.1. Australia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics For Atopic Dermatitis Market

  • 13.1. Indonesia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics For Atopic Dermatitis Market

  • 14.1. South Korea Digital Therapeutics For Atopic Dermatitis Market Overview
  • 14.2. South Korea Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics For Atopic Dermatitis Market

  • 15.1. Western Europe Digital Therapeutics For Atopic Dermatitis Market Overview
  • 15.2. Western Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics For Atopic Dermatitis Market

  • 16.1. UK Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics For Atopic Dermatitis Market

  • 17.1. Germany Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics For Atopic Dermatitis Market

  • 18.1. France Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics For Atopic Dermatitis Market

  • 19.1. Italy Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics For Atopic Dermatitis Market

  • 20.1. Spain Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market

  • 21.1. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market Overview
  • 21.2. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics For Atopic Dermatitis Market

  • 22.1. Russia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics For Atopic Dermatitis Market

  • 23.1. North America Digital Therapeutics For Atopic Dermatitis Market Overview
  • 23.2. North America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics For Atopic Dermatitis Market

  • 24.1. USA Digital Therapeutics For Atopic Dermatitis Market Overview
  • 24.2. USA Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics For Atopic Dermatitis Market

  • 25.1. Canada Digital Therapeutics For Atopic Dermatitis Market Overview
  • 25.2. Canada Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics For Atopic Dermatitis Market

  • 26.1. South America Digital Therapeutics For Atopic Dermatitis Market Overview
  • 26.2. South America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics For Atopic Dermatitis Market

  • 27.1. Brazil Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics For Atopic Dermatitis Market

  • 28.1. Middle East Digital Therapeutics For Atopic Dermatitis Market Overview
  • 28.2. Middle East Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics For Atopic Dermatitis Market

  • 29.1. Africa Digital Therapeutics For Atopic Dermatitis Market Overview
  • 29.2. Africa Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics For Atopic Dermatitis Market Competitive Landscape And Company Profiles

  • 30.1. Digital Therapeutics For Atopic Dermatitis Market Competitive Landscape
  • 30.2. Digital Therapeutics For Atopic Dermatitis Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Sanofi Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics For Atopic Dermatitis Market Other Major And Innovative Companies

  • 31.1. Otsuka Pharmaceutical Co. Ltd.
  • 31.2. OMRON Corporation
  • 31.3. Galderma S.A.
  • 31.4. Incyte Corporation
  • 31.5. Chugai Pharmaceutical Co. Ltd.
  • 31.6. Teladoc Health Inc.
  • 31.7. LEO Pharma A/S
  • 31.8. Almirall S.A.
  • 31.9. Biofourmis Inc.
  • 31.10. Click Therapeutics Inc.
  • 31.11. DarioHealth Corp.
  • 31.12. Sidekick Health GmbH
  • 31.13. Digital Diagnostics Inc.
  • 31.14. Liva Healthcare A/S
  • 31.15. 3Derm Systems

32. Global Digital Therapeutics For Atopic Dermatitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics For Atopic Dermatitis Market

34. Recent Developments In The Digital Therapeutics For Atopic Dermatitis Market

35. Digital Therapeutics For Atopic Dermatitis Market High Potential Countries, Segments and Strategies

  • 35.1 Digital Therapeutics For Atopic Dermatitis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Digital Therapeutics For Atopic Dermatitis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Digital Therapeutics For Atopic Dermatitis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer